Patents by Inventor Rosalia Mars-Groenendijk

Rosalia Mars-Groenendijk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial peptides based on CMAP27
    Patent number: 11186619
    Abstract: The invention concerns derivatives of CMAP27, which have a good antimicrobial activity and a low haemolytic activity as compared to the wild-type CMAP27 peptide. These derivatives can be used for antibiotic therapy or in a bacteriocidal composition. Further comprised in the invention is the use of CMAP27 and/or its derivatives as adjuvant.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: November 30, 2021
    Assignee: Universiteit Utrecht Holding B.V.
    Inventors: Floris Jacob Bikker, Albert van Dijk, Rosalia Mars-Groenendijk, Edwin Johannes Adrianus Veldhuizen, Desiree van der Kleij, Hendrik Haagsman, Elisabeth Margaretha Molhoek
  • Antimicrobial Peptides Based on CMAP27
    Publication number: 20190233483
    Abstract: The invention concerns derivatives of CMAP27, which have a good antimicrobial activity and a low haemolytic activity as compared to the wild-type CMAP27 peptide. These derivatives can be used for antibiotic therapy or in a bacteriocidal composition. Further comprised in the invention is the use of CMAP27 and/or its derivatives as adjuvant.
    Type: Application
    Filed: April 10, 2019
    Publication date: August 1, 2019
    Applicant: Universiteit Utrecht Holding B.V.
    Inventors: Floris Jacob Bikker, Albert van Dijk, Rosalia Mars-Groenendijk, Edwin Johannes Adrianus Veldhuizen, Desiree van der Kleij, Hendrik Haagsman, Elisabeth Margaretha Molhoek
  • Antimicrobial peptides based on CMAP27
    Patent number: 10301363
    Abstract: The invention concerns derivatives of CMAP27, which have a good antimicrobial activity and a low haemolytic activity as compared to the wild-type CMAP27 peptide. These derivatives can be used for antibiotic therapy or in a bacteriocidal composition. Further comprised in the invention is the use of CMAP27 and/or its derivatives as adjuvant.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: May 28, 2019
    Assignee: Universiteit Utrecht Holding B.V.
    Inventors: Floris Jacob Bikker, Albert van Dijk, Rosalia Mars-Groenendijk, Edwin Johannes Adrianus Veldhuizen, Desiree van der Kleij, Hendrik Haagsman, Elisabeth Margaretha Molhoek
  • ANTIMICROBIAL PEPTIDES BASED ON CMAP27
    Publication number: 20150197547
    Abstract: The invention concerns derivatives of CMAP27, which have a good antimicrobial activity and a low haemolytic activity as compared to the wild-type CMAP27 peptide. These derivatives can be used for antibiotic therapy or in a bacteriocidal composition. Further comprised in the invention is the use of CMAP27 and/or its derivatives as adjuvant.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Inventors: Floris Jacob Bikker, Albert van Dijk, Rosalia Mars-Groenendijk, Edwin Johannes Adrianus Veldhuizen, Desiree van der Kleij, Hendrik Haagsman, Elisabeth Margaretha Molhoek
  • Antimicrobial peptides based on CMAP27
    Patent number: 9006174
    Abstract: The invention concerns derivatives of CMAP27, which have a good antimicrobial activity and a low haemolytic activity as compared to the wild-type CMAP27 peptide. These derivatives can be used for antibiotic therapy or in a bacteriocidal composition. Further comprised in the invention is the use of CMAP27 and/or its derivatives as adjuvant.
    Type: Grant
    Filed: February 12, 2010
    Date of Patent: April 14, 2015
    Assignee: Universiteit Utrecht Holding B.V.
    Inventors: Floris Jacob Bikker, Albert Van Dijk, Rosalia Mars-Groenendijk, Edwin Johannes Adrianus Veldhuizen, Desiree Van Der Kleij, Hendrik Haagsman, Elisabeth Margaretha Molhoek
  • ANTIMICROBIAL PEPTIDES BASED ON CMAP27
    Publication number: 20120093844
    Abstract: The invention concerns derivatives of CMAP27, which have a good antimicrobial activity and a low haemolytic activity as compared to the wild-type CMAP27 peptide. These derivatives can be used for antibiotic therapy or in a bacteriocidal composition. Further comprised in the invention is the use of CMAP27 and/or its derivatives as adjuvant.
    Type: Application
    Filed: February 12, 2010
    Publication date: April 19, 2012
    Inventors: Floris Jacob Bikker, Albert Van Dijk, Rosalia Mars-Groenendijk, Edwin Johannes Adrianus Veldhuizen, Desiree Van Der Kleij, Hendrik Haagsman, Elisabeth Margaretha Molhoek